Platform provides comprehensive capabilities at affordable cost.

A new rule issued by HHS under the Trump administration allows physicians, hospitals and insurers to refuse care to certain patients on grounds of religious beliefs—something a New York Times columnist says could lead to “chaos in healthcare."

On February 15 of this year, Congress passed national breast density legislation, which mandates all mammography reports and summaries notify women of their breast density. A trio of researchers discussed whether the law will help or confuse patients in a recent JAMA commentary.

CMS has issued a new guidance to limit the prevalence of spread pricing in Medicaid and the Children’s Health Insurance Program (CHIP) as part of a broader effort to lower prescription drug costs.

DenseBreast-info.org (DB-I) has launched a new research study to evaluate how educational interventions affect a healthcare provider’s knowledge of breast density.

AI can speed up precise detection of one of the key signs of Alzheimer’s disease, according to researchers from University of California Davis and UC San Francisco, who published a study on their machine learning tool in Nature Communications.

A majority of French radiologists feel they don’t know enough about AI, according to a new study published in Diagnostic and Interventional Imaging. But they want to learn more and sound optimistic about the technology’s many benefits.

A team of U.S. researchers found the brains of patients diagnosed with severe mental illnesses—such as schizophrenia and depression—may have more in common than previously thought, according to a recent fMRI study.

The FDA is updating azithromycin drug labels to reflect evidence that the medication can contribute to a rare heart rhythm abnormality known as torsades de pointes.

Civica Rx, a not-for-profit drug company startup that aims to provide more affordable drugs, inked a new deal to distribute antibiotics with Xellia Pharmaceuticals, a specialty pharmaceutical company based in Copenhagen that develops, manufactures and commercializes anti-infective treatments.